Groups | Negative control | Low-dose group | Middle-dose group | High-dose group | |
After feeding samples for 3 months (n = 16) | PT (s) | 13.60 ± 0.43 | 13.30 ± 0.45 | 13.35 ± 0.54 | 13.34 ± 0.39 |
WBC (×109/L) | 6.14 ± 1.23 | 6.42 ± 1.30 | 6.30 ± 1.91 | 6.27 ± 1.48 | |
RBC (×1012/L) | 8.618 ± 0.439 | 8.909 ± 0.431 | 8.818 ± 0.578 | 8.887 ± 0.456 | |
HGB (g/dL) | 16.48 ± 0.60 | 17.12 ± 0.69** | 16.69 ± 0.87 | 17.28 ± 0.66** | |
HCT (%) | 47.69 ± 2.08 | 48.86 ± 1.97 | 47.71 ± 2.44 | 48.79 ± 2.28 | |
MCV (fL) | 54.3 ± 1.1 | 54.6 ± 1.3 | 54.3 ± 1.4 | 54.8 ± 1.1 | |
MCH (pg) | 18.92 ± 0.54 | 19.18 ± 0.60 | 18.86 ± 0.59 | 19.09 ± 0.55 | |
MCHC (g/dL) | 34.87 ± 0.39 | 35.03 ± 0.49 | 34.95 ± 0.29 | 34.91 ± 0.38 | |
RDW (%) | 11.44 ± 0.40 | 11.45 ± 0.32 | 11.44 ± 0.54 | 11.54 ± 0.32 | |
PLT (×109/L) | 866.5 ± 88.5 | 882.6 ± 128.4 | 920.2 ± 61.4 | 910.1 ± 62.8 | |
MPV (fL) | 7.44 ± 0.37 | 7.67 ± 0.51 | 7.44 ± 0.23 | 7.44 ± 0.37 | |
PCT (%) | 0.6362 ± 0.0730 | 0.6543 ± 0.1015 | 0.6681 ± 0.0583 | 0.6652 ± 0.0550 | |
After recovery for 2 weeks (n = 8) | PT (s) | 13.81 ± 0.41 | 13.38 ± 0.53 | 13.79 ± 0.45 | 13.79 ± 0.37 |
WBC (×109/L) | 6.00 ± 2.11 | 5.50 ± 0.94 | 5.74 ± 1.91 | 6.35 ± 1.14 | |
RBC (×1012/L) | 8.754 ± 0.657 | 8.904 ± 0.309 | 8.975 ± 0.625 | 9.074 ± 0.304 | |
HGB (g/dL) | 17.08 ± 1.14 | 17.05 ± 0.60 | 16.95 ± 0.75 | 17.21 ± 0.37 | |
HCT (%) | 47.91 ± 2.98 | 47.63 ± 1.71 | 47.88 ± 2.49 | 48.41 ± 0.66 | |
MCV (fL) | 54.4 ± 1.4 | 53.1 ± 1.1 | 53.8 ± 1.0 | 53.8 ± 1.0 | |
MCH (pg) | 19.45 ± 0.55 | 18.94 ± 0.53 | 19.13 ± 0.49 | 19.04 ± 0.46 | |
MCHC (g/dL) | 35.73 ± 0.21 | 35.61 ± 0.20 | 35.45 ± 0.43 | 35.58 ± 0.18 | |
RDW (%) | 10.84 ± 0.37 | 11.15 ± 0.26 | 11.10 ± 0.54 | 11.05 ± 0.40 | |
PLT (×109/L) | 874.1 ± 79.5 | 844.1 ± 42.2 | 904.3 ± 103.2 | 881.6 ± 94.9 | |
MPV (fL) | 7.65 ± 0.29 | 7.43 ± 0.19 | 7.39 ± 0.36 | 7.61 ± 0.33 | |
PCT (%) | 0.6655 ± 0.0554 | 0.6226 ± 0.0356 | 0.6683 ± 0.0988 | 0.6583 ± 0.0782 |